Sponsors and CROs choosing a randomization and trial supply management (RTSM, also called IRT) system for interventional trials.
Scope Sponsors and CROs choosing an RTSM/IRT system to randomize participants and manage investigational product supply in interventional trials. Site-side pharmacy tools and stand-alone supply planning software are out of scope.
These notes describe the products in the RTSM / IRT guide.
Medidata RTSM
Best for
Sponsors already on Rave EDC who want randomization and supply in the same system
What to consider
Medidata RTSM is unified with Rave EDC, so randomization and dispensing data do not need reconciling between two systems. Its fact sheets document block, stratified and dynamic allocation, supply forecasting, direct-to-patient shipping and post-go-live changes with little to no downtime. Pricing is not published.
Sponsors with complex randomization schemes, including minimization, who may also use YPrime eCOA
What to consider
YPrime names more randomization methods than any other vendor here, from permuted blocks to Pocock-Simon minimization, and publishes short build times. Its public IRT page does not describe supply forecasting or direct-to-patient shipping, and we found no named security certification.
Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.
Expand a feature definition or support note for context and its original source.
Medidata RTSM vs YPrime IRT (RTSM / IRT): category feature evidence and sources. Products are not ranked.
Category feature
Medidata RTSM
YPrime IRT
Randomization and blindingFeature definitions
Supported
Randomization or blinding workflows are stated.
Extended support
Named allocation methods include minimization or dynamic allocation.
Medidata RTSM
Extended support
A Medidata fact sheet lists pre-validated permuted block and dynamic allocation, stratification, cohort management, titration and a randomization simulator (fact sheet dated May 2019).
Named methods include permuted blocks and dynamic allocation with stratification.
YPrime IRT
Extended support
YPrime names permuted block and stratified randomization, dynamic allocation and minimization (Pocock and Simon), stratum caps and conditional re-randomization.
Named methods include permuted blocks, dynamic allocation and minimization.
Trial supply managementFeature definitions
Supported
Drug inventory, dispensing, shipping or resupply workflows are documented.
Extended support
Supply forecasting and direct-to-patient delivery (shipping or dispensing) are both documented.
Medidata RTSM
Extended support
The current fact sheet documents buffer and predictive supply schemes, forecasting that simulates future patient needs, direct-to-patient shipments and drug pooling across studies.
Predictive supply schemes and forecasting are documented alongside direct-to-patient shipments.
YPrime IRT
Supported
The IRT page covers inventory, orders, resupply, kit replacement and depot rules, but does not describe supply forecasting or direct-to-patient shipping.
Inventory and resupply establish base support; forecasting and direct-to-patient shipping are not described.
Study build speed and mid-study changesFeature definitions
Supported
Study setup or post-go-live study changes are described.
Extended support
Study setup is described, and post-go-live changes explicitly avoid interrupting live study use.
Medidata RTSM
Supported
Medidata states a 2-3 week study build, and Edit Live Design allows post-go-live changes for protocol amendments (the 2024 fact sheet adds 'little to no downtime').
A build timeline and live amendments are stated, but little-to-no downtime permits some interruption.
YPrime IRT
Supported
YPrime cites build to go-live in under four weeks for an early-phase oncology trial, about a week for the simplest designs, and self-service routine changes that take effect immediately.
Trial-system integrations establish base support; an API is not stated in this note.
Compliance and security evidenceFeature definitions
Supported
Relevant trial compliance or security controls are stated, with their scope identified.
Extended support
Relevant trial controls and a publicly accessible ISO certificate or SOC audit report covering the product or vendor are documented.
Medidata RTSM
Supported
Medidata lists an ISO 27001:2022 certificate and a SOC 2+ Type II audit, and says its position statements cover 21 CFR Part 11 and EU Annex 11 (the statements sit behind a customer login).